Revatio 20 mg FC tablets
PDF Leaflet Revision Date: 23 February 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of pulmonary arterial hypertension (PAH).
Dosage (summary)
20 mg three times a day, 6-8 hours apart.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy; low levels in breast milk.
Key Drug Interactions
- Erythromycin
- Saquinavir
- CYP3A4 inhibitors
- Bosentan
Contraindications
- Hypersensitivity
- Concurrent use with nitrates
- Severe hepatic impairment
- Severe renal impairment
- Blood pressure < 90/50 mmHg
Common side effects
- Headache
- Flushing
- Dyspepsia
- Back pain
- Diarrhoea
Counselling Points
- Take with or without food
- Avoid nitrates
- Seek help for prolonged erection
- Caution with driving due to dizziness
Serious warnings
- Risk of priapism
- Caution in cardiovascular disease
- Risk of NAION
Important Disclaimer
The Revatio 20 mg FC tablets professional information leaflet below is the property of Upjohn South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
